$23.130
+0.948 (+4.10%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de Attovia Therapeutics Inc?
Attovia Therapeutics, Inc. is a good buy right now due to its recent successful IPO that raised approximately $289 million, reflecting strong market interest. The stock is currently priced at $20.70, which is significantly lower than the analyst price target of $25, suggesting a potential upside of about 20.5%. Additionally, the forward P/E ratio of 4.81 indicates that the stock may be undervalued compared to future earnings expectations. However, the main risk is the negative net income reported for Q1 2026, which stands at -18.66 million USD, indicating ongoing financial challenges.
ATTO cerró en $23.13 el Wednesday, tras subir +4.10%
Attovia Therapeutics Inc (ATTO) last closed at $23.13, gaining +4.10%. These facts feed the 1-day and 1-week ATTO price prediction above.
Factores de la previsión
Los factores de la previsión de Attovia Therapeutics Inc (ATTO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bullish
Análisis de estacionalidad de ATTO
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.